UnitedHealth 2025 Outlook Clouded by Heartbreaking Loss of Key Leader

UnitedHealth Group Incorporated UNH recently issued its 2025 financial outlook ahead of its annual Investor Conference. Sadly, it faced a devastating event when Brian Thompson, CEO of its UnitedHealthcare division, was fatally shot in a targeted attack outside the New York Hilton Midtown early Wednesday morning. The company, headquartered in Minnetonka, MN, expressed deep sorrow, calling Thompson a dear friend and colleague and pledging cooperation with the NYPD's investigation.The attack comes as the company manages significant challenges, including regulatory scrutiny and a massive data breach affecting millions. The conference was ended early in the wake of Thompson's death.What Was in the 2025 Financial Outlook?UNH expects 2025 revenues in the range of $450-$455 billion. It projects 2025 adjusted net earnings to be $27.075-$27.675 billion, up from the 2024 estimated figure of $25.5-$25.775 billion. Furthermore, UnitedHealth expects 2025 adjusted earnings to be $29.50-$30 per share, up from the 2024 estimate figure of $27.50-$27.75.It anticipates medical care ratio for 2025 at 86.5% (± 50 basis points). This Zacks Rank #3 (Hold) company expects 2025 operating cash flows to be within $32-$33 billion and capital expenditures at around $4 billion. The UnitedHealthcare business is expected to cater to 50.97-51.32 million people in 2025.You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.UnitedHealth’s Win Against CMSLast month, afederal judge in Texas ordered the Centers for Medicare and Medicaid Services (CMS) to recalculate UnitedHealth’s Medicare Star Ratings for 2025. The court found that CMS violated the Administrative Procedure Act by incorrectly flagging a test call to UnitedHealthcare's call center as unsuccessful, unfairly impacting the company's ratings.The judge did not agree with UnitedHealthcare's argument that CMS applied a different standard to it than Elevance Health, Inc. ELV in evaluating its call center performance. However, the ruling offered hope to other Medicare Advantage insurers, such as Humana Inc. HUM and Centene Corporation CNC, as they contest their own star ratings.On Monday, the CMS released revised ratings, boosting stars for 12 UnitedHealth contracts and seven Centene contracts.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report Humana Inc. (HUM): Free Stock Analysis Report Centene Corporation (CNC): Free Stock Analysis Report Elevance Health, Inc. (ELV): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks